Wooridul Huebrain Limited (118000.KS)
KRW 298.0
(-1.32%)
KRW 298.0
(-1.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 155.3 Billion KRW | -18.2% |
| 2022 | 189.85 Billion KRW | 7.69% |
| 2021 | 176.3 Billion KRW | 27.49% |
| 2020 | 138.29 Billion KRW | 98.11% |
| 2019 | 69.8 Billion KRW | 13.61% |
| 2018 | 61.44 Billion KRW | 67.22% |
| 2017 | 36.74 Billion KRW | 27.38% |
| 2016 | 28.84 Billion KRW | 75.83% |
| 2015 | 16.4 Billion KRW | -16.61% |
| 2014 | 19.67 Billion KRW | -10.45% |
| 2013 | 21.96 Billion KRW | -27.71% |
| 2012 | 30.38 Billion KRW | -47.69% |
| 2011 | 58.08 Billion KRW | -23.44% |
| 2010 | 75.87 Billion KRW | 71.48% |
| 2009 | 44.25 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 123.1 Billion KRW | -20.73% |
| 2024 Q2 | 121.65 Billion KRW | -1.18% |
| 2023 Q2 | 191.65 Billion KRW | 1.58% |
| 2023 Q1 | 188.68 Billion KRW | -0.62% |
| 2023 FY | 155.3 Billion KRW | -18.2% |
| 2023 Q3 | 198.31 Billion KRW | 3.48% |
| 2023 Q4 | 155.3 Billion KRW | -21.69% |
| 2022 Q3 | 145.27 Billion KRW | -10.28% |
| 2022 Q1 | 175.17 Billion KRW | -0.64% |
| 2022 FY | 189.85 Billion KRW | 7.69% |
| 2022 Q4 | 189.85 Billion KRW | 30.69% |
| 2022 Q2 | 161.92 Billion KRW | -7.57% |
| 2021 Q1 | 142.94 Billion KRW | 3.36% |
| 2021 Q3 | 176.74 Billion KRW | 14.6% |
| 2021 Q4 | 176.3 Billion KRW | -0.25% |
| 2021 Q2 | 154.22 Billion KRW | 7.89% |
| 2021 FY | 176.3 Billion KRW | 27.49% |
| 2020 Q2 | 74.94 Billion KRW | 10.6% |
| 2020 Q4 | 138.29 Billion KRW | 12.42% |
| 2020 FY | 138.29 Billion KRW | 98.11% |
| 2020 Q1 | 67.75 Billion KRW | -2.93% |
| 2020 Q3 | 123.01 Billion KRW | 64.15% |
| 2019 Q1 | 54.63 Billion KRW | -11.08% |
| 2019 Q2 | 67.91 Billion KRW | 24.31% |
| 2019 FY | 69.8 Billion KRW | 13.61% |
| 2019 Q3 | 72.44 Billion KRW | 6.68% |
| 2019 Q4 | 69.8 Billion KRW | -3.65% |
| 2018 Q4 | 61.44 Billion KRW | -5.87% |
| 2018 Q3 | 65.26 Billion KRW | 127.48% |
| 2018 Q2 | 28.69 Billion KRW | -10.79% |
| 2018 FY | 61.44 Billion KRW | 67.22% |
| 2018 Q1 | 32.16 Billion KRW | -12.46% |
| 2017 Q1 | 29.32 Billion KRW | 1.67% |
| 2017 Q4 | 36.74 Billion KRW | -10.37% |
| 2017 FY | 36.74 Billion KRW | 27.38% |
| 2017 Q2 | 39.78 Billion KRW | 35.68% |
| 2017 Q3 | 40.99 Billion KRW | 3.02% |
| 2016 Q2 | 31.98 Billion KRW | 27.49% |
| 2016 FY | 28.84 Billion KRW | 75.83% |
| 2016 Q4 | 28.84 Billion KRW | -7.78% |
| 2016 Q3 | 31.27 Billion KRW | -2.21% |
| 2016 Q1 | 25.08 Billion KRW | 52.93% |
| 2015 FY | 16.4 Billion KRW | -16.61% |
| 2015 Q3 | 17.12 Billion KRW | -2.37% |
| 2015 Q2 | 17.54 Billion KRW | -6.12% |
| 2015 Q1 | 18.68 Billion KRW | -5.0% |
| 2015 Q4 | 16.4 Billion KRW | -4.23% |
| 2014 Q4 | 19.67 Billion KRW | -11.87% |
| 2014 FY | 19.67 Billion KRW | -10.45% |
| 2014 Q3 | 22.32 Billion KRW | -3.89% |
| 2014 Q2 | 23.22 Billion KRW | 17.88% |
| 2014 Q1 | 19.7 Billion KRW | -10.31% |
| 2013 FY | 21.96 Billion KRW | -27.71% |
| 2013 Q4 | 21.96 Billion KRW | 0.0% |
| 2012 Q2 | 41.31 Billion KRW | -14.01% |
| 2012 Q3 | 41.23 Billion KRW | -0.21% |
| 2012 Q4 | 30.38 Billion KRW | -26.29% |
| 2012 FY | 30.38 Billion KRW | -47.69% |
| 2012 Q1 | 48.04 Billion KRW | -17.29% |
| 2011 Q4 | 58.08 Billion KRW | -33.76% |
| 2011 Q3 | 87.7 Billion KRW | 1.45% |
| 2011 FY | 58.08 Billion KRW | -23.44% |
| 2011 Q1 | 94.64 Billion KRW | 24.73% |
| 2011 Q2 | 86.44 Billion KRW | -8.66% |
| 2010 FY | 75.87 Billion KRW | 71.48% |
| 2010 Q3 | 74.56 Billion KRW | -1.97% |
| 2010 Q1 | 79.25 Billion KRW | 0.0% |
| 2010 Q4 | 75.87 Billion KRW | 1.76% |
| 2010 Q2 | 76.06 Billion KRW | -4.03% |
| 2009 FY | 44.25 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Daewoong Co., Ltd. | 2359.27 Billion KRW | 93.417% |
| PharmGen Science, Inc. | 335.91 Billion KRW | 53.767% |